Triethylamine → HCID 18706628, compound
Reaction equation
[Br:1][CH2:2][C:3]1[CH:12]=[C:11]([N+:13]([O-:15])=[O:14])[CH:10]=[C:9]2[C:4]=1[N:5]=[C:6]([O:18]C)[C:7]([O:16]C)=[N:8]2.[CH3:20][CH:21]1[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]1.C(N(CC)CC)C>>[BrH:1].[O:16]=[C:7]1[C:6](=[O:18])[NH:5][C:4]2[C:9](=[CH:10][C:11]([N+:13]([O-:15])=[O:14])=[CH:12][C:3]=2[CH2:2][N:24]2[CH2:25][CH2:26][CH:21]([CH3:20])[CH2:22][CH2:23]2)[NH:8]1Participants
4
Procedure
100 mg (0.304 mmol) of 5-bromomethyl-2,3-dimethoxy-7-nitro-quinoxaline, 0.04 ml (1.1 equiv.) of 4-methyl-piperidine and 0.05 ml (1.2 equiv.) of triethylamine are stirred at reflux for 20 hours. The mixture is concentrated by evaporation and the residue is extracted with ethyl acetate and a 5% sodium carbonate solution. The combined organic phases are dried over magnesium sulfate and concentrated by evaporation.
Workup
- temperatureat reflux for 20 hours
- concentrationThe mixture is concentrated by evaporation
- extractionthe residue is extracted with ethyl acetate
- dry with materialThe combined organic phases are dried over magnesium sulfate
- concentrationconcentrated by evaporation
Sources & evidence
- ORD record
- ord-0a746e03a05b454e94163fd2d4a2afd2
- Source dataset
- uspto-grants-2000_06
- Patent number
- US06080743
Reaction notes
Loading…